Valentino Stella

University Distinguished Professor
Department of Pharmaceutical Chemistry, School of Pharmacy
Primary office:
Dolph Simons Bioscience Research Labs, room 121B

Expertise and Current Research Activity

My research involves novel ways of formulating and delivering to the body, problematic drug candidates, especially drugs used to treat cancer and AIDs. I am also the inventor or co-inventor of the drugs fosphenytoin (Cerebyx®), Viread®, Lusedra® and Captisol® the solubilizer used in the injectable forms of Vfend®, Geodon®, Abilify®, Nexterone® and the veterinary product Cerenia® and helped formulate the novel anticancer drug Velcade®.

I helped found three Kansas companies, Cydex Pharma, Crititech and ProQuest Pharma. All of the products are helping Kansans and others throughout the world live healthy and productive lives. I also helped establish the biosciences incubator in Lawrence and I am involved with the National Cancer Center designation for the University of Kansas.

One of 34 U.S. public institutions in the prestigious Association of American Universities
Nearly $290 million in financial aid annually
44 nationally ranked graduate programs.
—U.S. News & World Report
Top 50 nationwide for size of library collection.
23rd nationwide for service to veterans —"Best for Vets," Military Times
KU Today